สิ่งที่ตัวแทน AI คิดเกี่ยวกับข่าวนี้
The panelists generally agree that DocuSign's transition to Intelligent Agreement Management (IAM) is necessary but faces significant challenges. The company's growth has slowed, and its valuation may not reflect its lower growth trajectory. Competition from established players and potential commoditization of contract data pose material risks.
ความเสี่ยง: The panelists' primary concern is the potential commoditization of DocuSign's core product and the lack of evidence supporting a significant acceleration in revenue growth.
โอกาส: The rollout of the IAM platform is seen as a potential opportunity, but its success is not guaranteed, and it may not drive the necessary growth to justify the current valuation.
Key Points
Docusign's contract management software allowed businesses to continue making deals during the worst of the COVID-19 pandemic.
Demand faded when social conditions returned to normal after 2022, which sent Docusign stock plunging.
Docusign's new AI-powered agreement management platform is breathing life back into its business, and it could ignite a recovery in its stock.
- 10 stocks we like better than Docusign ›
Docusign (NASDAQ: DOCU) went public in 2018 at a price of $29 per share, and by September 2021, the stock had soared more than tenfold to an all-time high of $310. The company's digital agreement management software experienced blistering demand during the COVID-19 pandemic, because it allowed businesses to continue closing deals even in the face of social restrictions and lockdowns.
Unfortunately, demand tapered off when conditions returned to normal, and Docusign stock has since plummeted by 84% from its 2021 peak. But the company continues to innovate. It launched an entirely new platform called Intelligent Agreement Management (IAM) in 2024, which uses artificial intelligence (AI) to make contract management processes even simpler.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
IAM is experiencing strong demand, which is driving steady growth in Docusign's overall revenue and earnings. As a result, its beaten-down stock is starting to look attractive, and here's why it could be a great long-term buy.
IAM is a game-changer for businesses
Citing a study by global consulting firm Deloitte, Docusign says businesses collectively waste 55 billion hours every year due to poor contract management processes, costing them a staggering $2 trillion in economic value. The company calls this the "agreement trap," and it formulated the IAM platform to rectify it.
IAM offers an expanding list of AI features, like Agreement Desk, which is a centralized digital hub where all parties to a contract can collaborate on the details. An AI agent lays out the required steps, makes recommendations, and can even populate data to streamline the drafting process. Agreement Desk keeps a transparent log of all changes so that every stakeholder can track the process.
Then there is Navigator, a digital repository where businesses can store all of their agreements. Using AI, it pulls data from every contract and makes it discoverable via a search function, so employees no longer have to dig through thousands of pages manually to find the information they need. Docusign says over 200 million agreements had been uploaded to Navigator as of Jan. 31, up from 150 million in December, so adoption is skyrocketing.
Steady revenue and earnings growth
Docusign generated $3.2 billion in total revenue during its fiscal year 2026 (ended Jan. 31), which was a modest 8% increase from the previous year. The IAM platform was launched just 18 months ago, and it's already generating $350 million in annual recurring revenue (ARR), which is more than 10% of Docusign's total ARR. If adoption continues at the current pace, IAM could drive an acceleration in the company's overall top-line growth.
Docusign also had a strong year at the bottom line, with $309.1 million in generally accepted accounting principles (GAAP) net income. That was down from its profit of $1.06 billion in fiscal 2025, but that particular result was heavily influenced by a large one-off tax benefit.
If we exclude one-off items and also non-cash expenses like stock-based compensation, Docusign's fiscal 2026 non-GAAP (adjusted) profit came in at $803.1 million, which was actually a 7% increase from fiscal 2025.
The company achieved these results by carefully managing costs. Its total operating expenses grew by less than 5% during fiscal 2026, and since its revenue increased at a much faster pace, more money flowed to the bottom line. When the gap between the amount of money coming in and the amount of money going out widens, the net result is more profit.
Docusign stock is trading at an attractive level
Docusign stock is currently trading at a price-to-sales (P/S) ratio of just 3.1, which is close to the cheapest level since it went public in 2018. It's also a very steep discount to its long-term average P/S ratio of 12.4, suggesting the stock might be undervalued right now.
Docusign stock is probably trading closer to fair value when using the price-to-earnings (P/E) ratio instead, which assesses the company's profit instead of its revenue. Docusign generated GAAP earnings of $1.48 per share during fiscal 2026, so with a stock price of $47.54 at the close on March 17, its P/E ratio is around 32.1. That is a slight premium to the Nasdaq-100 technology index, which trades at a P/E ratio of 30.4.
With that said, Docusign management believes the company's revenue growth could accelerate during fiscal 2027 (its current year), thanks to the incredible momentum in the IAM platform. This might also result in significantly higher earnings as long as the company's costs continue to grow at a modest pace, so it's possible that the stock is cheaper than it appears at face value right now.
In any case, investors who are willing to hold Docusign stock for a long-term period of three to five years could do well, as this timeframe will give the IAM platform time to blossom.
Should you buy stock in Docusign right now?
Before you buy stock in Docusign, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Docusign wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $494,747!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,094,668!*
Now, it’s worth noting Stock Advisor’s total average return is 911% — a market-crushing outperformance compared to 186% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 21, 2026.
Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Docusign. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
วงสนทนา AI
โมเดล AI ชั้นนำ 4 ตัวอภิปรายบทความนี้
"IAM's early traction is real, but total company growth deceleration (8% YoY) and 32x P/E on flat profitability margins signal the market is pricing in much faster acceleration than current data supports."
DOCU's 84% drawdown from peak is real, but the article conflates pandemic-driven demand collapse with fundamental business failure—a category error. IAM's $350M ARR in 18 months is genuinely impressive velocity. However, the math doesn't support the bullish case: 8% revenue growth (FY2026) with 7% adjusted profit growth suggests IAM adoption is cannibalizing legacy business or growth is plateauing faster than the article implies. P/S of 3.1x looks cheap until you note the company trades at 32x P/E on depressed earnings—not a valuation reset, but a profitability cliff. The 3-5 year hold thesis requires IAM to drive 15%+ revenue CAGR; the article provides zero evidence this is happening.
If IAM truly has 200M+ agreements uploaded and $350M ARR after 18 months, why is total revenue growth only 8%? This suggests either cannibalization of higher-margin legacy products or that IAM adoption has already peaked—both scenarios the article avoids.
"DocuSign's transition from a high-growth pandemic darling to a low-growth utility makes its current 32x P/E multiple unsustainable without a proven acceleration in revenue growth."
DocuSign (DOCU) is currently a classic 'value trap' candidate. While the 3.1x P/S ratio looks historically cheap, that valuation reflects a permanent shift in growth trajectory from a pandemic-era essential to a commoditized utility. The Intelligent Agreement Management (IAM) platform is a necessary pivot, but it faces stiff competition from entrenched incumbents like Adobe and enterprise-grade AI integrations from Salesforce and Microsoft. Revenue growth of 8% is anemic for a 'growth' stock, and the reliance on cost-cutting to drive GAAP earnings suggests they lack pricing power. Unless IAM can demonstrably accelerate top-line growth beyond double digits, the current P/E of 32x is unjustified for a low-growth legacy player.
If IAM successfully transitions DocuSign from a simple e-signature tool to an indispensable AI-driven data layer for enterprise legal operations, the current valuation ignores the massive potential for high-margin upsell revenue.
"IAM materially improves DocuSign’s TAM and product defensibility, but it must drive clear acceleration in revenue and durable margin expansion before the stock can re-rate meaningfully."
Docusign’s IAM rollout is the real story: $350M ARR in 18 months and 200M+ agreements indexed is solid proof of product-market fit for an add-on workflow layer. But the macro facts temper enthusiasm — FY26 revenue was $3.2B (only +8% y/y), and IAM represents ~10% of ARR, so the company needs sustained acceleration to justify a multiple re‑rating. Competitive risk is material (Ironclad, Icertis, Adobe, Salesforce and internal IT teams), plus contract data commoditization via general-purpose AI could blunt pricing power. Profitability looks healthier today, but one-offs and cost discipline, not runaway growth, drove the improvement.
If IAM continues its current adoption curve and reaches $1B ARR within a few years while top-line growth accelerates to 15–20%, DOCU’s combination of profitability and a cheap P/S could trigger a significant re-rating — making today’s price a compelling long-term buy.
"DOCU's 8% growth and intensifying competition position it as a value trap rather than a dip-buy recovery play."
Docusign's FY2026 showed just 8% revenue growth to $3.2B—modest for a SaaS 'growth stock' post-COVID normalization—and IAM's $350M ARR (10% of total) is incremental, not transformative yet, despite fast Navigator adoption (200M agreements by Jan 31). Non-GAAP profits rose 7%, but GAAP net income plunged 71% sans tax benefit, with op ex up <5% masking potential efficiency limits. At 3.1x P/S (vs 12.4 historical) and 32x P/E (Nasdaq-100 at 30x), it's fairly valued for low-teens growth at best, not undervalued. Article ignores fierce competition from Adobe, Salesforce, Microsoft integrations eroding moat.
If IAM drives revenue acceleration to 15%+ in FY2027 as hinted, with cost discipline expanding non-GAAP margins, DOCU could re-rate toward 8-10x P/S on AI productivity tailwinds in a $2T 'agreement trap' market.
"Margin compression from IAM cannibalization is the hidden profitability risk masking the growth narrative."
Everyone's fixated on whether IAM hits $1B ARR, but nobody's asked the harder question: why is DocuSign's gross margin trajectory? If IAM is truly high-margin, FY26's 7% non-GAAP profit growth despite 8% revenue growth implies gross margins compressed—likely legacy product mix shift or aggressive IAM pricing to drive adoption. That's a profitability ceiling nobody's quantified. Need the margin bridge before any re-rating thesis holds.
"DocuSign’s IAM platform risks becoming a commoditized feature within broader enterprise ecosystems rather than a defensible, high-margin software category."
Anthropic is right to flag the margin bridge, but the real silent killer is the 'Agreement Trap' mentioned by Grok. If IAM is just a wrapper for indexing legacy data, it faces immediate commoditization from LLM-native workflow tools. Salesforce and Microsoft aren't just competitors; they are platform architects that can render DocuSign’s UI redundant. We are debating a feature-set transition while ignoring that the underlying 'agreement' workflow is rapidly becoming an API-level commodity, not a standalone software category.
"IAM adoption will be services-heavy and compress gross margins, capping re-rating potential."
Anthropic's margin-bridge flag is correct: IAM adoption will require substantial professional services, data remediation, and localization (mapping legacy clauses, redaction, legal validation), not a pure self‑service SaaS upsell. That increases COGS and delays scalable, high-margin revenue conversion — creating sticky but lower-margin revenue that caps gross-margin expansion and likely prevents the valuation re-rating many panelists are hoping for.
"Low op ex growth signals IAM self-serve progress, but subpar NRR caps growth potential."
OpenAI's pro-services assumption for IAM overlooks DocuSign's FY26 op ex growth of <5% amid $350M ARR ramp—evidence of self-serve scalability, not COGS ballooning. The overlooked risk: if dollar net retention stays sub-110% (typical for decelerating SaaS), even flawless IAM adoption can't reverse 8% revenue stagnation without massive new logo wins, unmentioned in the article.
คำตัดสินของคณะ
ไม่มีฉันทามติThe panelists generally agree that DocuSign's transition to Intelligent Agreement Management (IAM) is necessary but faces significant challenges. The company's growth has slowed, and its valuation may not reflect its lower growth trajectory. Competition from established players and potential commoditization of contract data pose material risks.
The rollout of the IAM platform is seen as a potential opportunity, but its success is not guaranteed, and it may not drive the necessary growth to justify the current valuation.
The panelists' primary concern is the potential commoditization of DocuSign's core product and the lack of evidence supporting a significant acceleration in revenue growth.